Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Vor Biopharma management to meet virtually with Oppenheimer » 11:19
01/18/22
01/18
11:19
01/18/22
11:19
VOR

Vor Biopharma

$9.04 /

-0.055 (-0.61%)

Virtual Meeting to be…

Virtual Meeting to be held on January 24 hosted by Oppenheimer.

ShowHide Related Items >><<
VOR Vor Biopharma
$9.04 /

-0.055 (-0.61%)

VOR Vor Biopharma
$9.04 /

-0.055 (-0.61%)

12/17/21 H.C. Wainwright
Vor Biopharma initiated with a Buy at H.C. Wainwright
12/03/21 Baird
Baird start Vor Biopharma with an Outperform ahead of AML data
12/02/21 Baird
Vor Biopharma initiated with an Outperform at Baird
12/01/21 Oppenheimer
Vor Biopharma initiated with an Outperform at Oppenheimer
VOR Vor Biopharma
$9.04 /

-0.055 (-0.61%)

  • 05
    Feb
Over a week ago
On The Fly
Wall Street in Fives - Must Read Lists for Thursday » 17:43
01/06/22
01/06
17:43
01/06/22
17:43
WBA

Walgreens Boots Alliance

$52.37 /

-1.74 (-3.22%)

, SYK

Stryker

$271.54 /

-0.81 (-0.30%)

, VCRA

Vocera

$79.18 /

+16.39 (+26.10%)

, BBBY

Bed Bath & Beyond

$14.43 /

+1.065 (+7.97%)

, DKS

Dick's Sporting

$108.08 /

+1.26 (+1.18%)

, HUM

Humana

$367.51 /

-88.47 (-19.40%)

, COIN

Coinbase

$233.85 /

-0.26 (-0.11%)

, BIRD

Allbirds

$15.22 /

+1.6 (+11.75%)

, TGT

Target

$231.36 /

+2.53 (+1.11%)

, GS

Goldman Sachs

$396.83 /

-1.85 (-0.46%)

, MSFT

Microsoft

$313.89 /

-2.11 (-0.67%)

, NYT

New York Times

$47.81 /

+2.125 (+4.65%)

, WMT

Walmart

$143.51 /

-0.44 (-0.31%)

, T

AT&T

$26.12 /

-0.1 (-0.38%)

, VIAC

ViacomCBS

$32.72 /

-0.01 (-0.03%)

, VIACA

ViacomCBS

$36.01 /

+0.01 (+0.03%)

, TOSYY

Toshiba

$20.95 /

-0.015 (-0.07%)

, RIVN

Rivian Automotive

$87.33 /

-2.675 (-2.97%)

, LW

Lamb Weston

$67.67 /

+4.51 (+7.14%)

, SFIX

Stitch Fix

$19.42 /

+1.78 (+10.09%)

, CRIS

Curis

$3.50 /

-1.325 (-27.49%)

, STRO

Sutro Biopharma

$10.51 /

-4.14 (-28.26%)

, CAG

Conagra Brands

$33.54 /

-0.61 (-1.79%)

, BLI

Berkeley Lights

$9.87 /

-6.39 (-39.30%)

, BBWI

Bath & Body Works

$62.34 /

-4.23 (-6.35%)

, STZ

Constellation Brands

$244.72 /

-8.675 (-3.42%)

, KIRK

Kirkland's

$16.05 /

+1.225 (+8.27%)

, STZ.B

Constellation Brands; also tag STZ

$248.00 /

+33.69 (+15.72%)

, SCHN

Schnitzer Steel

$46.09 /

-7.61 (-14.17%)

Get caught up quickly on…

ShowHide Related Items >><<
WMT Walmart
$143.51 /

-0.44 (-0.31%)

WBA Walgreens Boots Alliance
$52.37 /

-1.74 (-3.22%)

VIACA ViacomCBS
$36.01 /

+0.01 (+0.03%)

VIAC ViacomCBS
$32.72 /

-0.01 (-0.03%)

VCRA Vocera
$79.18 /

+16.39 (+26.10%)

TOSYY Toshiba
$20.95 /

-0.015 (-0.07%)

TGT Target
$231.36 /

+2.53 (+1.11%)

T AT&T
$26.12 /

-0.1 (-0.38%)

SYK Stryker
$271.54 /

-0.81 (-0.30%)

STZ Constellation Brands
$244.72 /

-8.675 (-3.42%)

STRO Sutro Biopharma
$10.51 /

-4.14 (-28.26%)

SFIX Stitch Fix
$19.42 /

+1.78 (+10.09%)

SCHN Schnitzer Steel
$46.09 /

-7.61 (-14.17%)

RIVN Rivian Automotive
$87.33 /

-2.675 (-2.97%)

NYT New York Times
$47.81 /

+2.125 (+4.65%)

MSFT Microsoft
$313.89 /

-2.11 (-0.67%)

LW Lamb Weston
$67.67 /

+4.51 (+7.14%)

KIRK Kirkland's
$16.05 /

+1.225 (+8.27%)

HUM Humana
$367.51 /

-88.47 (-19.40%)

GS Goldman Sachs
$396.83 /

-1.85 (-0.46%)

DKS Dick's Sporting
$108.08 /

+1.26 (+1.18%)

CRIS Curis
$3.50 /

-1.325 (-27.49%)

COIN Coinbase
$233.85 /

-0.26 (-0.11%)

CAG Conagra Brands
$33.54 /

-0.61 (-1.79%)

BLI Berkeley Lights
$9.87 /

-6.39 (-39.30%)

BBWI Bath & Body Works
$62.34 /

-4.23 (-6.35%)

BBBY Bed Bath & Beyond
$14.43 /

+1.065 (+7.97%)

WBA Walgreens Boots Alliance
$52.37 /

-1.74 (-3.22%)

12/22/21 UBS
Walgreens Boots Alliance price target raised to $52 from $50 at UBS
12/22/21 Baird
Walgreens Boots Alliance price target raised to $70 from $68 at Baird
12/17/21 Morgan Stanley
Walgreens Boots Alliance downgraded to Underweight at Morgan Stanley
12/16/21 Morgan Stanley
Walgreens Boots Alliance downgraded to Underweight from Equal Weight at Morgan Stanley
SYK Stryker
$271.54 /

-0.81 (-0.30%)

01/07/22 Cowen
Stryker deal bolsters it complementary product portfolio, says Cowen
01/07/22 Craig-Hallum
Vocera downgraded to Hold from Buy at Craig-Hallum
01/07/22 Morgan Stanley
Stryker downgraded to Equal Weight at Morgan Stanley on relative valuation
01/07/22 Baird
Vocera downgraded to Neutral from Outperform at Baird
VCRA Vocera
$79.18 /

+16.39 (+26.10%)

01/06/22 BTIG
Vocera downgraded to Neutral from Buy at BTIG
BBBY Bed Bath & Beyond
$14.43 /

+1.065 (+7.97%)

01/07/22 Loop Capital
Bed Bath & Beyond price target lowered to $10 from $14 at Loop Capital
01/07/22 B. Riley
Bed Bath & Beyond price target lowered to $19 from $28 at B. Riley
01/07/22 Baird
Bed Bath & Beyond price target lowered to $14 from $22 at Baird
01/03/22 Wedbush
Bed Bath & Beyond price target lowered to $14 from $18 at Wedbush
DKS Dick's Sporting
$108.08 /

+1.26 (+1.18%)

01/07/22 Evercore ISI
Evercore shifts portfolio to 'value oriented' retail names for 2022
01/06/22 Baird
Dick's Sporting price target lowered to $125 from $140 at Baird
01/05/22 Wedbush
Wedbush adds Dick's Sporting to Best Ideas List, lowers price target to $140
12/22/21 Cowen
Dick's Sporting price target lowered to $145 from $180 at Cowen
HUM Humana
$367.51 /

-88.47 (-19.40%)

01/07/22 BMO Capital
Humana price target lowered to $415 from $490 at BMO Capital
01/07/22 Wells Fargo
Humana price target lowered to $452 from $529 at Wells Fargo
01/07/22 Deutsche Bank
Humana price target lowered to $418 from $476 at Deutsche Bank
01/07/22 Barclays
Humana price target lowered to $490 from $540 at Barclays
COIN Coinbase
$233.85 /

-0.26 (-0.11%)

01/07/22 JPMorgan
JPMorgan sees greater acceptance for crypto, says Coinbase a buy
01/07/22 JPMorgan
JPMorgan sees greater acceptance for crypto, says Coinbase a buy
01/06/22 BofA
Coinbase upgraded to Buy at BofA on revenue diversification
01/06/22 BofA
Coinbase upgraded to Buy from Neutral at BofA
BIRD Allbirds
$15.22 /

+1.6 (+11.75%)

01/06/22 Morgan Stanley
Allbirds upgraded to Overweight from Equal Weight at Morgan Stanley
01/03/22 Guggenheim
Nike remains a 'Best Idea' at Guggenheim heading into 2022
12/01/21 Morgan Stanley
Morgan Stanley says Allbirds investors may have been seeking upside
11/29/21
Fly Intel: Top five analyst initiations
TGT Target
$231.36 /

+2.53 (+1.11%)

01/07/22 Deutsche Bank
Target price target lowered to $312 from $318 at Deutsche Bank
01/06/22 Wells Fargo
Wells Fargo downgrades Target to Equal Weight, cuts price target to $230
01/06/22 Wells Fargo
Target downgraded to Equal Weight from Overweight at Wells Fargo
GS Goldman Sachs
$396.83 /

-1.85 (-0.46%)

01/06/22 BofA
Goldman Sachs downgraded to Neutral from Buy at BofA
01/03/22 Barclays
Goldman Sachs price target raised to $556 from $483 at Barclays
12/06/21 Morgan Stanley
Goldman Sachs upgraded to Equal Weight at Morgan Stanley
12/06/21 Morgan Stanley
Goldman Sachs upgraded to Equal Weight from Underweight at Morgan Stanley
MSFT Microsoft
$313.89 /

-2.11 (-0.67%)

01/06/22 Jefferies
Microsoft price target raised to $400 from $375 at Jefferies
12/21/21 SMBC Nikko
SMBC Nikko starts Microsoft at Outperform, sees 28% upside
12/21/21 SMBC Nikko
Microsoft initiated with an Outperform at SMBC Nikko
12/14/21 Morgan Stanley
Microsoft's leading position in data management overlooked, says Morgan Stanley
NYT New York Times
$47.81 /

+2.125 (+4.65%)

12/06/21 Wolfe Research
New York Times downgraded to Peer Perform from Outperform at Wolfe Research
11/02/21 Morgan Stanley
New York Times price target raised to $65 from $60 at Morgan Stanley
05/06/21 JPMorgan
New York Times shares may be range-bound near term, says JPMorgan
03/18/21 Guggenheim
Guggenheim upgrades News Corp. to Buy, sees 'significant value' to be unlocked
WMT Walmart
$143.51 /

-0.44 (-0.31%)

01/07/22 Jefferies
Jefferies upgraded Trade Desk to Buy, highlights five reasons to be positive
01/06/22 MKM Partners
Walmart may be having better winter than expected, MKM Partners
12/29/21 DA Davidson
DA Davidson bullish on Mattel, Hasbro as out-of-stocks of toys 'notably higher'
T AT&T
$26.12 /

-0.1 (-0.38%)

01/07/22 Wells Fargo
AT&T upgraded to Equal Weight from Underweight at Wells Fargo
12/23/21
Fly Intel: Top five analyst initiations
12/23/21 Daiwa
AT&T initiated with a Neutral at Daiwa
VIAC ViacomCBS
$32.72 /

-0.01 (-0.03%)

12/14/21 Macquarie
ViacomCBS price target lowered to $32 from $40 at Macquarie
10/15/21 Deutsche Bank
ViacomCBS price target lowered to $44 from $45 at Deutsche Bank
08/18/21
Fly Intel: Top five analyst upgrades
08/18/21 Wells Fargo
ViacomCBS upgraded to Overweight from Equal Weight at Wells Fargo
VIACA ViacomCBS
$36.01 /

+0.01 (+0.03%)

TOSYY Toshiba
$20.95 /

-0.015 (-0.07%)

07/28/21 SMBC Nikko
Toshiba downgraded to Neutral from Outperform at SMBC Nikko
03/19/21 SMBC Nikko
Toshiba upgraded to Outperform from Neutral at SMBC Nikko
02/19/21 Citi
Toshiba resumed with a Neutral at Citi
RIVN Rivian Automotive
$87.33 /

-2.675 (-2.97%)

01/06/22 Morgan Stanley
Morgan Stanley wants exposure to Rivian, says expectations need to be managed
01/05/22 Wells Fargo
Ambarella price target raised to $205 from $185 at Wells Fargo
01/05/22 Mizuho
Tesla price target raised to $1,300 from $950 at Mizuho
01/04/22 Morgan Stanley
Ferrari replacing GM as Morgan Stanley's new 'Top Pick' in U.S. autos
LW Lamb Weston
$67.67 /

+4.51 (+7.14%)

10/08/21 Jefferies
Lamb Weston reaching bottom after Q1 'clearing event,' says Jefferies
07/28/21 JPMorgan
Lamb Weston earnings selloff a buying opportunity, says JPMorgan
06/08/21 Jefferies
Jefferies upgrades Lamb Weston to Buy on demand recovery, pricing power
06/08/21 Jefferies
Lamb Weston upgraded to Buy from Hold at Jefferies
SFIX Stitch Fix
$19.42 /

+1.78 (+10.09%)

12/15/21 JPMorgan
Stitch Fix price target lowered to $20 from $25 at JPMorgan
12/08/21
Fly Intel: Top five analyst downgrades
12/08/21 BMO Capital
Stitch Fix price target lowered to $25 from $40 at BMO Capital
12/08/21 Wedbush
Stitch Fix price target lowered to $21 from $45 at Wedbush
CRIS Curis
$3.50 /

-1.325 (-27.49%)

01/03/22 B. Riley
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022
10/13/21
Fly Intel: Top five analyst initiations
10/13/21 Raymond James
Curis initiated with an Outperform at Raymond James
05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
STRO Sutro Biopharma
$10.51 /

-4.14 (-28.26%)

01/06/22 Wedbush
Sutro Biopharma price target lowered to $30 from $37 at Wedbush
11/17/21 Berenberg
Sutro Biopharma initiated with a Buy at Berenberg
06/18/21
Fly Intel: Top five analyst initiations
06/18/21 H.C. Wainwright
Sutro Biopharma initiated with a Buy at H.C. Wainwright
CAG Conagra Brands
$33.54 /

-0.61 (-1.79%)

01/07/22 Deutsche Bank
Conagra Brands price target lowered to $35 from $36 at Deutsche Bank
10/08/21 JPMorgan
Conagra downgraded on limited earnings upside at JPMorgan
10/08/21 JPMorgan
Conagra Brands downgraded to Neutral from Overweight at JPMorgan
09/29/21
Fly Intel: Top five analyst upgrades
BLI Berkeley Lights
$9.87 /

-6.39 (-39.30%)

01/06/22 Stifel
Stifel downgrades Berkeley Lights, sees stock as 'dead money for a while'
01/06/22 William Blair
Berkeley Lights downgraded to Market Perform from Outperform at William Blair
01/06/22 BTIG
Berkeley Lights price target lowered to $25 from $45 at BTIG
01/06/22 Stifel
Berkeley Lights downgraded to Sell from Hold at Stifel
BBWI Bath & Body Works
$62.34 /

-4.23 (-6.35%)

01/07/22 Deutsche Bank
Bath & Body Works price target lowered to $85 from $87 at Deutsche Bank
01/07/22 Citi
Bath & Body Works price target lowered to $93 from $100 at Citi
12/14/21
Fly Intel: Top five analyst initiations
12/14/21 Goldman Sachs
Bath & Body Works initiated with a Buy at Goldman Sachs
STZ Constellation Brands
$244.72 /

-8.675 (-3.42%)

01/07/22 Argus
Constellation Brands price target raised to $290 from $272 at Argus
01/07/22 UBS
Constellation Brands price target raised to $285 from $270 at UBS
01/04/22 Wells Fargo
Constellation Brands price target raised to $300 from $265 at Wells Fargo
01/03/22 Jefferies
Constellation Brands price target raised to $316 from $305 at Jefferies
KIRK Kirkland's
$16.05 /

+1.225 (+8.27%)

10/15/21
Fly Intel: Top five analyst initiations
10/15/21 Benchmark
Kirkland's initiated with a Buy at Benchmark
09/03/21 Craig-Hallum
Kirkland's price target raised to $40 from $37 at Craig-Hallum
04/06/21 Sidoti
Kirkland's re-initiated with a Buy at Sidoti
STZ.B Constellation Brands; also tag STZ
$248.00 /

+33.69 (+15.72%)

SCHN Schnitzer Steel
$46.09 /

-7.61 (-14.17%)

07/19/21
Fly Intel: Top five analyst initiations
07/19/21 Northland
Schnitzer Steel initiated with an Outperform at Northland
04/09/21 Goldman Sachs
Schnitzer Steel initiated with a Buy at Goldman Sachs
01/12/21 KeyBanc
Schnitzer Steel downgraded to Sector Weight from Overweight at KeyBanc
WMT Walmart
$143.51 /

-0.44 (-0.31%)

WBA Walgreens Boots Alliance
$52.37 /

-1.74 (-3.22%)

VIAC ViacomCBS
$32.72 /

-0.01 (-0.03%)

VCRA Vocera
$79.18 /

+16.39 (+26.10%)

TGT Target
$231.36 /

+2.53 (+1.11%)

T AT&T
$26.12 /

-0.1 (-0.38%)

SYK Stryker
$271.54 /

-0.81 (-0.30%)

STZ.B Constellation Brands; also tag STZ
$248.00 /

+33.69 (+15.72%)

STZ Constellation Brands
$244.72 /

-8.675 (-3.42%)

STRO Sutro Biopharma
$10.51 /

-4.14 (-28.26%)

SFIX Stitch Fix
$19.42 /

+1.78 (+10.09%)

SCHN Schnitzer Steel
$46.09 /

-7.61 (-14.17%)

RIVN Rivian Automotive
$87.33 /

-2.675 (-2.97%)

NYT New York Times
$47.81 /

+2.125 (+4.65%)

MSFT Microsoft
$313.89 /

-2.11 (-0.67%)

LW Lamb Weston
$67.67 /

+4.51 (+7.14%)

KIRK Kirkland's
$16.05 /

+1.225 (+8.27%)

HUM Humana
$367.51 /

-88.47 (-19.40%)

GS Goldman Sachs
$396.83 /

-1.85 (-0.46%)

DKS Dick's Sporting
$108.08 /

+1.26 (+1.18%)

CRIS Curis
$3.50 /

-1.325 (-27.49%)

COIN Coinbase
$233.85 /

-0.26 (-0.11%)

CAG Conagra Brands
$33.54 /

-0.61 (-1.79%)

BLI Berkeley Lights
$9.87 /

-6.39 (-39.30%)

BIRD Allbirds
$15.22 /

+1.6 (+11.75%)

BBWI Bath & Body Works
$62.34 /

-4.23 (-6.35%)

BBBY Bed Bath & Beyond
$14.43 /

+1.065 (+7.97%)

  • 10
    Nov
  • 03
    Nov
  • 14
    Apr
  • 06
    Apr
  • 29
    Mar
  • 24
    Mar
WMT Walmart
$143.51 /

-0.44 (-0.31%)

WBA Walgreens Boots Alliance
$52.37 /

-1.74 (-3.22%)

VIACA ViacomCBS
$36.01 /

+0.01 (+0.03%)

VIAC ViacomCBS
$32.72 /

-0.01 (-0.03%)

TOSYY Toshiba
$20.95 /

-0.015 (-0.07%)

TGT Target
$231.36 /

+2.53 (+1.11%)

T AT&T
$26.12 /

-0.1 (-0.38%)

STZ Constellation Brands
$244.72 /

-8.675 (-3.42%)

SFIX Stitch Fix
$19.42 /

+1.78 (+10.09%)

RIVN Rivian Automotive
$87.33 /

-2.675 (-2.97%)

NYT New York Times
$47.81 /

+2.125 (+4.65%)

MSFT Microsoft
$313.89 /

-2.11 (-0.67%)

HUM Humana
$367.51 /

-88.47 (-19.40%)

GS Goldman Sachs
$396.83 /

-1.85 (-0.46%)

COIN Coinbase
$233.85 /

-0.26 (-0.11%)

BLI Berkeley Lights
$9.87 /

-6.39 (-39.30%)

BBBY Bed Bath & Beyond
$14.43 /

+1.065 (+7.97%)

WMT Walmart
$143.51 /

-0.44 (-0.31%)

WBA Walgreens Boots Alliance
$52.37 /

-1.74 (-3.22%)

VIACA ViacomCBS
$36.01 /

+0.01 (+0.03%)

VIAC ViacomCBS
$32.72 /

-0.01 (-0.03%)

VCRA Vocera
$79.18 /

+16.39 (+26.10%)

TOSYY Toshiba
$20.95 /

-0.015 (-0.07%)

TGT Target
$231.36 /

+2.53 (+1.11%)

T AT&T
$26.12 /

-0.1 (-0.38%)

SYK Stryker
$271.54 /

-0.81 (-0.30%)

STZ.B Constellation Brands; also tag STZ
$248.00 /

+33.69 (+15.72%)

STZ Constellation Brands
$244.72 /

-8.675 (-3.42%)

STRO Sutro Biopharma
$10.51 /

-4.14 (-28.26%)

SFIX Stitch Fix
$19.42 /

+1.78 (+10.09%)

SCHN Schnitzer Steel
$46.09 /

-7.61 (-14.17%)

RIVN Rivian Automotive
$87.33 /

-2.675 (-2.97%)

NYT New York Times
$47.81 /

+2.125 (+4.65%)

MSFT Microsoft
$313.89 /

-2.11 (-0.67%)

LW Lamb Weston
$67.67 /

+4.51 (+7.14%)

KIRK Kirkland's
$16.05 /

+1.225 (+8.27%)

HUM Humana
$367.51 /

-88.47 (-19.40%)

GS Goldman Sachs
$396.83 /

-1.85 (-0.46%)

DKS Dick's Sporting
$108.08 /

+1.26 (+1.18%)

COIN Coinbase
$233.85 /

-0.26 (-0.11%)

BIRD Allbirds
$15.22 /

+1.6 (+11.75%)

BBWI Bath & Body Works
$62.34 /

-4.23 (-6.35%)

BBBY Bed Bath & Beyond
$14.43 /

+1.065 (+7.97%)

WMT Walmart
$143.51 /

-0.44 (-0.31%)

WBA Walgreens Boots Alliance
$52.37 /

-1.74 (-3.22%)

VIAC ViacomCBS
$32.72 /

-0.01 (-0.03%)

TGT Target
$231.36 /

+2.53 (+1.11%)

T AT&T
$26.12 /

-0.1 (-0.38%)

STZ Constellation Brands
$244.72 /

-8.675 (-3.42%)

SFIX Stitch Fix
$19.42 /

+1.78 (+10.09%)

RIVN Rivian Automotive
$87.33 /

-2.675 (-2.97%)

MSFT Microsoft
$313.89 /

-2.11 (-0.67%)

LW Lamb Weston
$67.67 /

+4.51 (+7.14%)

HUM Humana
$367.51 /

-88.47 (-19.40%)

GS Goldman Sachs
$396.83 /

-1.85 (-0.46%)

DKS Dick's Sporting
$108.08 /

+1.26 (+1.18%)

COIN Coinbase
$233.85 /

-0.26 (-0.11%)

BIRD Allbirds
$15.22 /

+1.6 (+11.75%)

BBWI Bath & Body Works
$62.34 /

-4.23 (-6.35%)

BBBY Bed Bath & Beyond
$14.43 /

+1.065 (+7.97%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:02
01/06/22
01/06
12:02
01/06/22
12:02
WBA

Walgreens Boots Alliance

$53.15 /

-0.96 (-1.77%)

, SYK

Stryker

$274.15 /

+1.8 (+0.66%)

, VCRA

Vocera

$79.10 /

+16.31 (+25.98%)

, BBBY

Bed Bath & Beyond

$14.30 /

+0.935 (+7.00%)

, DKS

Dick's Sporting

$110.22 /

+3.4 (+3.18%)

, HUM

Humana

$407.55 /

-48.43 (-10.62%)

, NYT

New York Times

$46.23 /

+0.545 (+1.19%)

, WMT

Walmart

$143.46 /

-0.49 (-0.34%)

, T

AT&T

$26.19 /

-0.03 (-0.11%)

, VIAC

ViacomCBS

$33.07 /

+0.34 (+1.04%)

, VIACA

ViacomCBS

$36.32 /

+0.32 (+0.89%)

, TOSYY

Toshiba

$20.97 /

+0.195 (+0.94%)

, SBUX

Starbucks

$110.93 /

+0.48 (+0.43%)

, LW

Lamb Weston

$69.11 /

+5.95 (+9.42%)

, SFIX

Stitch Fix

$19.62 /

+1.98 (+11.22%)

, CRIS

Curis

$3.51 /

-1.31 (-27.18%)

, STRO

Sutro Biopharma

$10.82 /

-3.83 (-26.14%)

, CAG

Conagra Brands

$33.33 /

-0.82 (-2.40%)

, BLI

Berkeley Lights

$10.26 /

-6 (-36.90%)

, BBWI

Bath & Body Works

$62.89 /

-3.68 (-5.53%)

, STZ

Constellation Brands

$247.53 /

-5.865 (-2.31%)

, STZ.B

Constellation Brands; also tag STZ

$258.33 /

+44.02 (+20.54%)

, SCHN

Schnitzer Steel

$48.10 /

-5.6 (-10.43%)

, COIN

Coinbase

$231.90 /

-2.21 (-0.94%)

, BIRD

Allbirds

$14.72 /

+1.1 (+8.08%)

, TGT

Target

$229.95 /

+1.12 (+0.49%)

, MSFT

Microsoft

$314.95 /

-1.05 (-0.33%)

, GS

Goldman Sachs

$393.02 /

-5.66 (-1.42%)

, KIRK

Kirkland's

$16.01 /

+1.19 (+8.03%)

Get caught up quickly on…

ShowHide Related Items >><<
WMT Walmart
$143.46 /

-0.49 (-0.34%)

WBA Walgreens Boots Alliance
$53.15 /

-0.96 (-1.77%)

VIACA ViacomCBS
$36.32 /

+0.32 (+0.89%)

VIAC ViacomCBS
$33.07 /

+0.34 (+1.04%)

VCRA Vocera
$79.10 /

+16.31 (+25.98%)

TOSYY Toshiba
$20.97 /

+0.195 (+0.94%)

TGT Target
$229.95 /

+1.12 (+0.49%)

T AT&T
$26.19 /

-0.03 (-0.11%)

SYK Stryker
$274.15 /

+1.8 (+0.66%)

STZ Constellation Brands
$247.53 /

-5.865 (-2.31%)

STRO Sutro Biopharma
$10.82 /

-3.83 (-26.14%)

SFIX Stitch Fix
$19.62 /

+1.98 (+11.22%)

SCHN Schnitzer Steel
$48.10 /

-5.6 (-10.43%)

SBUX Starbucks
$110.93 /

+0.48 (+0.43%)

NYT New York Times
$46.23 /

+0.545 (+1.19%)

MSFT Microsoft
$314.95 /

-1.05 (-0.33%)

LW Lamb Weston
$69.11 /

+5.95 (+9.42%)

KIRK Kirkland's
$16.01 /

+1.19 (+8.03%)

HUM Humana
$407.55 /

-48.43 (-10.62%)

GS Goldman Sachs
$393.02 /

-5.66 (-1.42%)

DKS Dick's Sporting
$110.22 /

+3.4 (+3.18%)

CRIS Curis
$3.51 /

-1.31 (-27.18%)

COIN Coinbase
$231.90 /

-2.21 (-0.94%)

CAG Conagra Brands
$33.33 /

-0.82 (-2.40%)

BLI Berkeley Lights
$10.26 /

-6 (-36.90%)

BBWI Bath & Body Works
$62.89 /

-3.68 (-5.53%)

BBBY Bed Bath & Beyond
$14.30 /

+0.935 (+7.00%)

WBA Walgreens Boots Alliance
$53.15 /

-0.96 (-1.77%)

12/22/21 UBS
Walgreens Boots Alliance price target raised to $52 from $50 at UBS
12/22/21 Baird
Walgreens Boots Alliance price target raised to $70 from $68 at Baird
12/17/21 Morgan Stanley
Walgreens Boots Alliance downgraded to Underweight at Morgan Stanley
12/16/21 Morgan Stanley
Walgreens Boots Alliance downgraded to Underweight from Equal Weight at Morgan Stanley
SYK Stryker
$274.15 /

+1.8 (+0.66%)

01/06/22 BTIG
Stryker deal for Vocera 'a natural fit,' says BTIG
01/04/22 Piper Sandler
Zimmer Biomet downgraded to Neutral from Overweight at Piper Sandler
01/04/22 Piper Sandler
Stryker upgraded to Overweight from Neutral at Piper Sandler
12/15/21 Citi
Stryker price target lowered to $300 from $307 at Citi
VCRA Vocera
$79.10 /

+16.31 (+25.98%)

01/06/22 Jefferies
Vocera downgraded to Hold from Buy at Jefferies
01/06/22 William Blair
Vocera downgraded to Market Perform from Outperform at William Blair
12/20/21 Craig-Hallum
Vocera price target raised to $71 from $62 at Craig-Hallum
BBBY Bed Bath & Beyond
$14.30 /

+0.935 (+7.00%)

01/03/22 Wedbush
Bed Bath & Beyond price target lowered to $14 from $18 at Wedbush
11/03/21
Fly Intel: Top five analyst downgrades
11/03/21 Loop Capital
Loop Capital cuts Bed Bath & Beyond to Sell, cites deterioration in relevance
11/03/21 Loop Capital
Bed Bath & Beyond downgraded to Sell from Hold at Loop Capital
DKS Dick's Sporting
$110.22 /

+3.4 (+3.18%)

01/05/22 Wedbush
Wedbush adds Dick's Sporting to Best Ideas List, lowers price target to $140
12/22/21 Cowen
Dick's Sporting price target lowered to $145 from $180 at Cowen
12/17/21 Gordon Haskett
Target downgraded to Hold from Buy yesterday at Gordon Haskett
12/17/21 Gordon Haskett
Dick's Sporting downgraded to Hold from Buy at Gordon Haskett (yesterday)
HUM Humana
$407.55 /

-48.43 (-10.62%)

01/06/22 Wells Fargo
Wells Fargo upgrades Humana to Overweight, raises price target to $529
01/06/22 Wells Fargo
Humana upgraded to Overweight from Equal Weight at Wells Fargo
01/05/22 Truist
Humana price target raised to $520 from $500 at Truist
12/17/21 Morgan Stanley
Humana downgraded to Equal Weight at Morgan Stanley
NYT New York Times
$46.23 /

+0.545 (+1.19%)

12/06/21 Wolfe Research
New York Times downgraded to Peer Perform from Outperform at Wolfe Research
11/02/21 Morgan Stanley
New York Times price target raised to $65 from $60 at Morgan Stanley
05/06/21 JPMorgan
New York Times shares may be range-bound near term, says JPMorgan
03/18/21 Guggenheim
Guggenheim upgrades News Corp. to Buy, sees 'significant value' to be unlocked
WMT Walmart
$143.46 /

-0.49 (-0.34%)

01/06/22 MKM Partners
Walmart may be having better winter than expected, MKM Partners
01/03/22 Guggenheim
Nike remains a 'Best Idea' at Guggenheim heading into 2022
12/29/21 DA Davidson
DA Davidson bullish on Mattel, Hasbro as out-of-stocks of toys 'notably higher'
12/15/21 Jefferies
Bloomin', Callaway, Newell among five 'Franchise Picks' additions at Jefferies
T AT&T
$26.19 /

-0.03 (-0.11%)

12/23/21
Fly Intel: Top five analyst initiations
12/23/21 Daiwa
AT&T initiated with a Neutral at Daiwa
12/20/21
Fly Intel: Top five analyst upgrades
12/20/21 Barclays
Barclays upgrades AT&T on valuation, Warner deal benefits
VIAC ViacomCBS
$33.07 /

+0.34 (+1.04%)

12/14/21 Macquarie
ViacomCBS price target lowered to $32 from $40 at Macquarie
10/15/21 Deutsche Bank
ViacomCBS price target lowered to $44 from $45 at Deutsche Bank
08/18/21
Fly Intel: Top five analyst upgrades
08/18/21 Wells Fargo
ViacomCBS upgraded to Overweight from Equal Weight at Wells Fargo
VIACA ViacomCBS
$36.32 /

+0.32 (+0.89%)

TOSYY Toshiba
$20.97 /

+0.195 (+0.94%)

07/28/21 SMBC Nikko
Toshiba downgraded to Neutral from Outperform at SMBC Nikko
03/19/21 SMBC Nikko
Toshiba upgraded to Outperform from Neutral at SMBC Nikko
02/19/21 Citi
Toshiba resumed with a Neutral at Citi
SBUX Starbucks
$110.93 /

+0.48 (+0.43%)

12/29/21 MKM Partners
MKM Partners positive on Starbucks' workforce reputation and capital position
12/28/21 Tigress Financial
Starbucks price target raised to $136 from $130 at Tigress Financial
12/17/21
Fly Intel: Top five analyst downgrades
12/17/21 Baird
Baird downgrades Starbucks to Neutral on China uncertainty
LW Lamb Weston
$69.11 /

+5.95 (+9.42%)

10/08/21 Jefferies
Lamb Weston reaching bottom after Q1 'clearing event,' says Jefferies
07/28/21 JPMorgan
Lamb Weston earnings selloff a buying opportunity, says JPMorgan
06/08/21 Jefferies
Jefferies upgrades Lamb Weston to Buy on demand recovery, pricing power
06/08/21 Jefferies
Lamb Weston upgraded to Buy from Hold at Jefferies
SFIX Stitch Fix
$19.62 /

+1.98 (+11.22%)

12/15/21 JPMorgan
Stitch Fix price target lowered to $20 from $25 at JPMorgan
12/08/21
Fly Intel: Top five analyst downgrades
12/08/21 BMO Capital
Stitch Fix price target lowered to $25 from $40 at BMO Capital
12/08/21 Wedbush
Stitch Fix price target lowered to $21 from $45 at Wedbush
CRIS Curis
$3.51 /

-1.31 (-27.18%)

01/03/22 B. Riley
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022
10/13/21
Fly Intel: Top five analyst initiations
10/13/21 Raymond James
Curis initiated with an Outperform at Raymond James
05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
STRO Sutro Biopharma
$10.82 /

-3.83 (-26.14%)

01/06/22 Wedbush
Sutro Biopharma price target lowered to $30 from $37 at Wedbush
11/17/21 Berenberg
Sutro Biopharma initiated with a Buy at Berenberg
06/18/21
Fly Intel: Top five analyst initiations
06/18/21 H.C. Wainwright
Sutro Biopharma initiated with a Buy at H.C. Wainwright
CAG Conagra Brands
$33.33 /

-0.82 (-2.40%)

10/08/21 JPMorgan
Conagra downgraded on limited earnings upside at JPMorgan
10/08/21 JPMorgan
Conagra Brands downgraded to Neutral from Overweight at JPMorgan
09/29/21
Fly Intel: Top five analyst upgrades
09/29/21 Credit Suisse
Conagra Brands upgraded to Neutral from Underperform at Credit Suisse
BLI Berkeley Lights
$10.26 /

-6 (-36.90%)

01/06/22 Stifel
Stifel downgrades Berkeley Lights, sees stock as 'dead money for a while'
01/06/22 William Blair
Berkeley Lights downgraded to Market Perform from Outperform at William Blair
01/06/22 BTIG
Berkeley Lights price target lowered to $25 from $45 at BTIG
01/06/22 Stifel
Berkeley Lights downgraded to Sell from Hold at Stifel
BBWI Bath & Body Works
$62.89 /

-3.68 (-5.53%)

12/14/21
Fly Intel: Top five analyst initiations
12/14/21 Goldman Sachs
Bath & Body Works initiated with a Buy at Goldman Sachs
11/19/21 Morgan Stanley
Bath & Body Works price target raised to $90 from $84 at Morgan Stanley
11/19/21 B. Riley
Bath & Body Works price target raised to $91 from $86 at B. Riley
STZ Constellation Brands
$247.53 /

-5.865 (-2.31%)

01/04/22 Wells Fargo
Constellation Brands price target raised to $300 from $265 at Wells Fargo
01/03/22 Jefferies
Constellation Brands price target raised to $316 from $305 at Jefferies
01/03/22 Morgan Stanley
Constellation Brands price target raised to $303 from $254 at Morgan Stanley
01/03/22 JPMorgan
Constellation Brands price target raised to $283 from $275 at JPMorgan
STZ.B Constellation Brands; also tag STZ
$258.33 /

+44.02 (+20.54%)

SCHN Schnitzer Steel
$48.10 /

-5.6 (-10.43%)

07/19/21
Fly Intel: Top five analyst initiations
07/19/21 Northland
Schnitzer Steel initiated with an Outperform at Northland
04/09/21 Goldman Sachs
Schnitzer Steel initiated with a Buy at Goldman Sachs
01/12/21 KeyBanc
Schnitzer Steel downgraded to Sector Weight from Overweight at KeyBanc
COIN Coinbase
$231.90 /

-2.21 (-0.94%)

01/06/22 BofA
Coinbase upgraded to Buy at BofA on revenue diversification
01/06/22 BofA
Coinbase upgraded to Buy from Neutral at BofA
12/22/21 Oppenheimer
Coinbase, Nasdaq named Top Picks at Oppenheimer
11/10/21 Canaccord
Coinbase price target raised to $342 from $325 at Canaccord
BIRD Allbirds
$14.72 /

+1.1 (+8.08%)

01/06/22 Morgan Stanley
Allbirds upgraded to Overweight from Equal Weight at Morgan Stanley
12/01/21 Morgan Stanley
Morgan Stanley says Allbirds investors may have been seeking upside
11/29/21
Fly Intel: Top five analyst initiations
TGT Target
$229.95 /

+1.12 (+0.49%)

01/06/22 Wells Fargo
Wells Fargo downgrades Target to Equal Weight, cuts price target to $230
01/06/22 Wells Fargo
Target downgraded to Equal Weight from Overweight at Wells Fargo
MSFT Microsoft
$314.95 /

-1.05 (-0.33%)

01/06/22 Jefferies
Microsoft price target raised to $400 from $375 at Jefferies
12/21/21 SMBC Nikko
SMBC Nikko starts Microsoft at Outperform, sees 28% upside
12/21/21 SMBC Nikko
Microsoft initiated with an Outperform at SMBC Nikko
12/14/21 Morgan Stanley
Microsoft's leading position in data management overlooked, says Morgan Stanley
GS Goldman Sachs
$393.02 /

-5.66 (-1.42%)

01/06/22 BofA
Goldman Sachs downgraded to Neutral from Buy at BofA
01/03/22 Barclays
Goldman Sachs price target raised to $556 from $483 at Barclays
12/06/21 Morgan Stanley
Goldman Sachs upgraded to Equal Weight at Morgan Stanley
12/06/21 Morgan Stanley
Goldman Sachs upgraded to Equal Weight from Underweight at Morgan Stanley
KIRK Kirkland's
$16.01 /

+1.19 (+8.03%)

10/15/21
Fly Intel: Top five analyst initiations
10/15/21 Benchmark
Kirkland's initiated with a Buy at Benchmark
09/03/21 Craig-Hallum
Kirkland's price target raised to $40 from $37 at Craig-Hallum
04/06/21 Sidoti
Kirkland's re-initiated with a Buy at Sidoti
WMT Walmart
$143.46 /

-0.49 (-0.34%)

WBA Walgreens Boots Alliance
$53.15 /

-0.96 (-1.77%)

VIAC ViacomCBS
$33.07 /

+0.34 (+1.04%)

VCRA Vocera
$79.10 /

+16.31 (+25.98%)

TGT Target
$229.95 /

+1.12 (+0.49%)

T AT&T
$26.19 /

-0.03 (-0.11%)

SYK Stryker
$274.15 /

+1.8 (+0.66%)

STZ.B Constellation Brands; also tag STZ
$258.33 /

+44.02 (+20.54%)

STZ Constellation Brands
$247.53 /

-5.865 (-2.31%)

STRO Sutro Biopharma
$10.82 /

-3.83 (-26.14%)

SFIX Stitch Fix
$19.62 /

+1.98 (+11.22%)

SCHN Schnitzer Steel
$48.10 /

-5.6 (-10.43%)

SBUX Starbucks
$110.93 /

+0.48 (+0.43%)

NYT New York Times
$46.23 /

+0.545 (+1.19%)

MSFT Microsoft
$314.95 /

-1.05 (-0.33%)

LW Lamb Weston
$69.11 /

+5.95 (+9.42%)

KIRK Kirkland's
$16.01 /

+1.19 (+8.03%)

HUM Humana
$407.55 /

-48.43 (-10.62%)

GS Goldman Sachs
$393.02 /

-5.66 (-1.42%)

DKS Dick's Sporting
$110.22 /

+3.4 (+3.18%)

CRIS Curis
$3.51 /

-1.31 (-27.18%)

COIN Coinbase
$231.90 /

-2.21 (-0.94%)

CAG Conagra Brands
$33.33 /

-0.82 (-2.40%)

BLI Berkeley Lights
$10.26 /

-6 (-36.90%)

BIRD Allbirds
$14.72 /

+1.1 (+8.08%)

BBWI Bath & Body Works
$62.89 /

-3.68 (-5.53%)

BBBY Bed Bath & Beyond
$14.30 /

+0.935 (+7.00%)

  • 03
    Nov
  • 14
    Apr
  • 06
    Apr
  • 29
    Mar
  • 24
    Mar
WMT Walmart
$143.46 /

-0.49 (-0.34%)

WBA Walgreens Boots Alliance
$53.15 /

-0.96 (-1.77%)

VIACA ViacomCBS
$36.32 /

+0.32 (+0.89%)

VIAC ViacomCBS
$33.07 /

+0.34 (+1.04%)

TOSYY Toshiba
$20.97 /

+0.195 (+0.94%)

TGT Target
$229.95 /

+1.12 (+0.49%)

T AT&T
$26.19 /

-0.03 (-0.11%)

STZ Constellation Brands
$247.53 /

-5.865 (-2.31%)

SFIX Stitch Fix
$19.62 /

+1.98 (+11.22%)

SBUX Starbucks
$110.93 /

+0.48 (+0.43%)

NYT New York Times
$46.23 /

+0.545 (+1.19%)

MSFT Microsoft
$314.95 /

-1.05 (-0.33%)

HUM Humana
$407.55 /

-48.43 (-10.62%)

GS Goldman Sachs
$393.02 /

-5.66 (-1.42%)

COIN Coinbase
$231.90 /

-2.21 (-0.94%)

BLI Berkeley Lights
$10.26 /

-6 (-36.90%)

BBBY Bed Bath & Beyond
$14.30 /

+0.935 (+7.00%)

WMT Walmart
$143.46 /

-0.49 (-0.34%)

WBA Walgreens Boots Alliance
$53.15 /

-0.96 (-1.77%)

VIACA ViacomCBS
$36.32 /

+0.32 (+0.89%)

VIAC ViacomCBS
$33.07 /

+0.34 (+1.04%)

TOSYY Toshiba
$20.97 /

+0.195 (+0.94%)

TGT Target
$229.95 /

+1.12 (+0.49%)

T AT&T
$26.19 /

-0.03 (-0.11%)

SYK Stryker
$274.15 /

+1.8 (+0.66%)

STZ.B Constellation Brands; also tag STZ
$258.33 /

+44.02 (+20.54%)

STZ Constellation Brands
$247.53 /

-5.865 (-2.31%)

STRO Sutro Biopharma
$10.82 /

-3.83 (-26.14%)

SFIX Stitch Fix
$19.62 /

+1.98 (+11.22%)

SCHN Schnitzer Steel
$48.10 /

-5.6 (-10.43%)

SBUX Starbucks
$110.93 /

+0.48 (+0.43%)

NYT New York Times
$46.23 /

+0.545 (+1.19%)

MSFT Microsoft
$314.95 /

-1.05 (-0.33%)

LW Lamb Weston
$69.11 /

+5.95 (+9.42%)

KIRK Kirkland's
$16.01 /

+1.19 (+8.03%)

HUM Humana
$407.55 /

-48.43 (-10.62%)

GS Goldman Sachs
$393.02 /

-5.66 (-1.42%)

DKS Dick's Sporting
$110.22 /

+3.4 (+3.18%)

COIN Coinbase
$231.90 /

-2.21 (-0.94%)

CAG Conagra Brands
$33.33 /

-0.82 (-2.40%)

BLI Berkeley Lights
$10.26 /

-6 (-36.90%)

BIRD Allbirds
$14.72 /

+1.1 (+8.08%)

BBWI Bath & Body Works
$62.89 /

-3.68 (-5.53%)

BBBY Bed Bath & Beyond
$14.30 /

+0.935 (+7.00%)

WMT Walmart
$143.46 /

-0.49 (-0.34%)

WBA Walgreens Boots Alliance
$53.15 /

-0.96 (-1.77%)

VIAC ViacomCBS
$33.07 /

+0.34 (+1.04%)

TGT Target
$229.95 /

+1.12 (+0.49%)

T AT&T
$26.19 /

-0.03 (-0.11%)

STZ Constellation Brands
$247.53 /

-5.865 (-2.31%)

SFIX Stitch Fix
$19.62 /

+1.98 (+11.22%)

SBUX Starbucks
$110.93 /

+0.48 (+0.43%)

MSFT Microsoft
$314.95 /

-1.05 (-0.33%)

LW Lamb Weston
$69.11 /

+5.95 (+9.42%)

HUM Humana
$407.55 /

-48.43 (-10.62%)

GS Goldman Sachs
$393.02 /

-5.66 (-1.42%)

DKS Dick's Sporting
$110.22 /

+3.4 (+3.18%)

COIN Coinbase
$231.90 /

-2.21 (-0.94%)

BIRD Allbirds
$14.72 /

+1.1 (+8.08%)

BBWI Bath & Body Works
$62.89 /

-3.68 (-5.53%)

BBBY Bed Bath & Beyond
$14.30 /

+0.935 (+7.00%)

Options
Unusually active option classes on open January 6th » 09:40
01/06/22
01/06
09:40
01/06/22
09:40
EAR

Eargo

$4.56 /

+ (+0.00%)

, CSLT

Castlight Health

$2.03 /

+ (+0.00%)

, CRIS

Curis

$4.82 /

+ (+0.00%)

, BBBY

Bed Bath & Beyond

$13.37 /

+ (+0.00%)

, DB

Deutsche Bank

$13.18 /

+ (+0.00%)

, WBA

Walgreens Boots Alliance

$54.11 /

+ (+0.00%)

, ET

Energy Transfer LP

$8.80 /

+ (+0.00%)

, IBM

IBM

$138.22 /

+ (+0.00%)

, SQQQ

ProShares UltraPro Short QQQ

$6.53 /

+ (+0.00%)

, CRM

Salesforce

$227.65 /

+0.01 (+0.00%)

Unusual total active…

Unusual total active option classes on open include: Eargo (EAR), Castlight Health (CSLT), Curis (CRIS), Bed Bath & Beyond (BBBY), Deutsche Bank (DB), Walgreen Boots (WBA), Energy Transfer (ET), IBM (IBM), ProShares UltraPro Short QQQ (SQQQ), and Salesforce (CRM).

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$54.11 /

+ (+0.00%)

IBM IBM
$138.22 /

+ (+0.00%)

ET Energy Transfer LP
$8.80 /

+ (+0.00%)

EAR Eargo
$4.56 /

+ (+0.00%)

DB Deutsche Bank
$13.18 /

+ (+0.00%)

CSLT Castlight Health
$2.03 /

+ (+0.00%)

CRM Salesforce
$227.65 /

+0.01 (+0.00%)

CRIS Curis
$4.82 /

+ (+0.00%)

BBBY Bed Bath & Beyond
$13.37 /

+ (+0.00%)

EAR Eargo
$4.56 /

+ (+0.00%)

09/23/21
Fly Intel: Top five analyst downgrades
09/23/21 William Blair
William Blair downgrades Eargo on 'multiple unknowns' from criminal probe
09/23/21 Wells Fargo
Wells Fargo cuts Eargo to Equal Weight, slashes price target $10 from $52
09/23/21 William Blair
Eargo downgraded to Market Perform from Outperform at William Blair
CSLT Castlight Health
$2.03 /

+ (+0.00%)

CRIS Curis
$4.82 /

+ (+0.00%)

01/03/22 B. Riley
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022
10/13/21
Fly Intel: Top five analyst initiations
10/13/21 Raymond James
Curis initiated with an Outperform at Raymond James
05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
BBBY Bed Bath & Beyond
$13.37 /

+ (+0.00%)

01/03/22 Wedbush
Bed Bath & Beyond price target lowered to $14 from $18 at Wedbush
11/03/21
Fly Intel: Top five analyst downgrades
11/03/21 Loop Capital
Loop Capital cuts Bed Bath & Beyond to Sell, cites deterioration in relevance
11/03/21 Loop Capital
Bed Bath & Beyond downgraded to Sell from Hold at Loop Capital
DB Deutsche Bank
$13.18 /

+ (+0.00%)

12/06/21 JPMorgan
Deutsche Bank price target raised to EUR 15 from EUR 13.50 at JPMorgan
12/06/21 JPMorgan
Deutsche Bank upgraded to Overweight on cost management at JPMorgan
12/05/21 JPMorgan
Deutsche Bank upgraded to Overweight from Neutral at JPMorgan
11/29/21 Morgan Stanley
Deutsche Bank price target raised to EUR 14.20 from EUR 13.50 at Morgan Stanley
WBA Walgreens Boots Alliance
$54.11 /

+ (+0.00%)

12/22/21 UBS
Walgreens Boots Alliance price target raised to $52 from $50 at UBS
12/22/21 Baird
Walgreens Boots Alliance price target raised to $70 from $68 at Baird
12/17/21 Morgan Stanley
Walgreens Boots Alliance downgraded to Underweight at Morgan Stanley
12/16/21 Morgan Stanley
Walgreens Boots Alliance downgraded to Underweight from Equal Weight at Morgan Stanley
ET Energy Transfer LP
$8.80 /

+ (+0.00%)

12/07/21 Mizuho
OGE Energy downgraded to Neutral on valuation at Mizuho
09/28/21 BofA
BofA reinstates coverage of U.S. Midstream sector with six buys, four sells
09/28/21 BofA
Energy Transfer LP reinstated with a Buy at BofA
09/21/21 Tudor Pickering
Energy Transfer LP upgraded to Buy from Hold at Tudor Pickering
IBM IBM
$138.22 /

+ (+0.00%)

12/07/21 Credit Suisse
IBM assumed with an Outperform at Credit Suisse
12/02/21 Evercore ISI
IBM resumed with an In Line at Evercore ISI
10/28/21 Credit Suisse
IBM assumed with an Outperform at Credit Suisse
10/21/21 Morgan Stanley
IBM's Q3 'a pause on the path to improving growth,' says Morgan Stanley
SQQQ ProShares UltraPro Short QQQ
$6.53 /

+ (+0.00%)

CRM Salesforce
$227.65 /

+0.01 (+0.00%)

01/04/22 UBS
UBS downgrades Salesforce into 'more modest growth rate upside'
01/04/22 UBS
Salesforce downgraded to Neutral from Buy at UBS
12/22/21 Evercore ISI
Salesforce named as software top pick into 2022 at Evercore ISI
12/02/21 Needham
Veeva price target lowered to $327 from $385 at Needham
WBA Walgreens Boots Alliance
$54.11 /

+ (+0.00%)

IBM IBM
$138.22 /

+ (+0.00%)

ET Energy Transfer LP
$8.80 /

+ (+0.00%)

EAR Eargo
$4.56 /

+ (+0.00%)

DB Deutsche Bank
$13.18 /

+ (+0.00%)

CSLT Castlight Health
$2.03 /

+ (+0.00%)

CRM Salesforce
$227.65 /

+0.01 (+0.00%)

CRIS Curis
$4.82 /

+ (+0.00%)

BBBY Bed Bath & Beyond
$13.37 /

+ (+0.00%)

  • 08
    Dec
WBA Walgreens Boots Alliance
$54.11 /

+ (+0.00%)

IBM IBM
$138.22 /

+ (+0.00%)

ET Energy Transfer LP
$8.80 /

+ (+0.00%)

DB Deutsche Bank
$13.18 /

+ (+0.00%)

CRM Salesforce
$227.65 /

+0.01 (+0.00%)

BBBY Bed Bath & Beyond
$13.37 /

+ (+0.00%)

WBA Walgreens Boots Alliance
$54.11 /

+ (+0.00%)

IBM IBM
$138.22 /

+ (+0.00%)

ET Energy Transfer LP
$8.80 /

+ (+0.00%)

EAR Eargo
$4.56 /

+ (+0.00%)

DB Deutsche Bank
$13.18 /

+ (+0.00%)

CRM Salesforce
$227.65 /

+0.01 (+0.00%)

BBBY Bed Bath & Beyond
$13.37 /

+ (+0.00%)

WBA Walgreens Boots Alliance
$54.11 /

+ (+0.00%)

SQQQ ProShares UltraPro Short QQQ
$6.53 /

+ (+0.00%)

IBM IBM
$138.22 /

+ (+0.00%)

ET Energy Transfer LP
$8.80 /

+ (+0.00%)

EAR Eargo
$4.56 /

+ (+0.00%)

DB Deutsche Bank
$13.18 /

+ (+0.00%)

CSLT Castlight Health
$2.03 /

+ (+0.00%)

CRM Salesforce
$227.65 /

+0.01 (+0.00%)

BBBY Bed Bath & Beyond
$13.37 /

+ (+0.00%)

Hot Stocks
Curis reports Phase 1 data of CI-8993 in relapsed or refractory solid tumors » 07:17
01/06/22
01/06
07:17
01/06/22
07:17
CRIS

Curis

$4.82 /

-0.32 (-6.23%)

Curis announced initial…

Curis announced initial safety, pharmacokinetic and pharmacodynamic data from the Phase 1 dose escalation study of CI-8993, a monoclonal antibody targeting VISTA for patients with R/R solid tumors. Based on 13 patients treated in the first two dose cohorts of 0.15mg/kg and 0.3mg/kg, Curis believes CI-8993 has shown a promising safety profile to date, with no dose-limiting toxicities observed. The trial has successfully dose escalated through the 0.15 mg/kg and 0.3 mg/kg cohorts, the dose level at which Janssen discontinued a prior study after a patient experienced a reversible grade 3 treatment-related adverse event. In the current Curis study, CI-8993 has shown non-linear increases in pharmacokinetic exposure at each dose level and exhibits saturation kinetics, indicating the potential to overcome this sink effect as dose increases. These findings suggest the potential for broad bioavailability at higher dose levels. The pharmacodynamic effects of CI-8993 observed to date suggest the possibility that CI-8993 can activate multiple anti-cancer immune mechanisms, including mechanisms that are not addressed by currently approved checkpoint inhibitors. Curis intends to further explore this PK/PD relationship at higher dose levels, as the study continues. Curis expects to report expanded safety and tolerability data, along with initial PK, PD and anti-cancer data from the trial in the second half of 2022.

ShowHide Related Items >><<
CRIS Curis
$4.82 /

-0.32 (-6.23%)

CRIS Curis
$4.82 /

-0.32 (-6.23%)

01/03/22 B. Riley
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022
10/13/21
Fly Intel: Top five analyst initiations
10/13/21 Raymond James
Curis initiated with an Outperform at Raymond James
05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
CRIS Curis
$4.82 /

-0.32 (-6.23%)

Hot Stocks
Curis' CA-4948 monotherapy shows positive activity in Phase 1/2 AML study » 07:13
01/06/22
01/06
07:13
01/06/22
07:13
CRIS

Curis

$4.82 /

-0.32 (-6.23%)

Curis announced positive…

Curis announced positive updated clinical data from the ongoing open label Phase 1/2 dose escalation and expansion study of CA-4948, a novel, small molecule IRAK-4 inhibitor, as a monotherapy in patients with relapsed or refractory - R/R - acute myeloid leukemia, or AML, or high risk myelodysplastic syndromes - MDS -. As of December 16, 2021, 49 total patients had been administered CA-4948 in the R/R AML/MDS study. The safety profile to date showed key findings: CA-4948 was well-tolerated across multiple dose levels; treatment-related adverse events were reversible and manageable; no dose-limiting myelosuppression; no cumulative toxicities observed; no grade 4 or 5 treatment-related adverse events. The company believes these attributes of CA-4948's emerging safety profile may provide an advantage compared to current standard of care therapies in monotherapy and could also make CA-4948 an attractive candidate for addition to combination therapy regimens. Previous data presented by Curis in June 2021 highlighted preliminary efficacy data of CA-4948 in R/R AML/MDS patients whose disease is characterized by spliceosome or FLT3 mutation. The clinical data update provides an expanded data set for this genetically-defined patient population and further support the rationale for seeking a discussion with FDA in the first half of 2022 to discuss the potential for a rapid registrational path forward for CA-4948 as a monotherapy in genetically-defined patient populations. The company believes the data suggest a favorable safety and anti-cancer activity profile compared to standard of care therapies for these patient populations. Enrollment in the study of CA-4948 in R/R AML/MDS is on-going, and Curis looks forward to potential discussions with the FDA in the first half of 2022 regarding the potential for a rapid registrational path forward for CA-4948 as a monotherapy in genetically-defined patient populations. Curis expects to provide additional data from the R/R AML/MDS study at a medical meeting in 2022.

ShowHide Related Items >><<
CRIS Curis
$4.82 /

-0.32 (-6.23%)

CRIS Curis
$4.82 /

-0.32 (-6.23%)

01/03/22 B. Riley
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022
10/13/21
Fly Intel: Top five analyst initiations
10/13/21 Raymond James
Curis initiated with an Outperform at Raymond James
05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
CRIS Curis
$4.82 /

-0.32 (-6.23%)

Recommendations
iStar, Aspen Aerogels among B. Riley's top 25 stock picks for 2022 » 08:07
01/03/22
01/03
08:07
01/03/22
08:07
FRG

Franchise Group

$52.16 /

-0.325 (-0.62%)

, EVRI

Everi Holdings

$21.36 /

+0.22 (+1.04%)

, TGH

Textainer

$35.66 /

+0.1 (+0.28%)

, GSAT

Globalstar

$1.16 /

+ (+0.00%)

, DHX

DHI Group

$6.25 /

+0.16 (+2.63%)

, DBRG

DigitalBridge

$8.34 /

+ (+0.00%)

, SIMO

Silicon Motion

$95.02 /

+1.06 (+1.13%)

, STAR

iStar

$25.84 /

-0.025 (-0.10%)

, VCTR

Victory Capital

$36.62 /

+0.16 (+0.44%)

, LPTH

LightPath

$2.43 /

-0.02 (-0.82%)

, CMCT

CIM Commercial Trust

$7.24 /

-0.26 (-3.47%)

, DHC

Diversified Healthcare Trust

$3.10 /

+0.13 (+4.38%)

, ARWR

Arrowhead

$66.34 /

-1.05 (-1.56%)

, CUBI

Customers Bancorp

$65.40 /

+0.9 (+1.40%)

, SMSI

Smith Micro

$4.91 /

-0.01 (-0.20%)

, ALLO

Allogene Therapeutics

$14.94 /

-0.43 (-2.80%)

, SDIG

Stronghold Digital Mining

$12.83 /

+0.43 (+3.47%)

, ALTG

Alta Equipment Group

$14.63 /

+0.38 (+2.67%)

, UTI

Universal Technical

$7.86 /

+ (+0.00%)

, RWAY

Runway Growth Finance

$12.85 /

+0.01 (+0.08%)

, ASPN

Aspen Aerogels

$49.70 /

+0.73 (+1.49%)

, JYNT

Joint Corp.

$65.63 /

+1.12 (+1.74%)

, CRIS

Curis

$4.76 /

-0.01 (-0.21%)

, LFMD

LifeMD

$3.87 /

-0.2 (-4.91%)

, RMBL

RumbleON

$41.81 /

-0.69 (-1.62%)

Analysts at B. Riley…

Analysts at B. Riley announced their top 25 Picks for 2022. The list includes Franchise Group (FRG), Everi Holdings (EVRI), Textainer (TGH), Globalstar (GSAT), DHI Group (DHX), DigitalBridge (DBRG), Silicon Motion (SIMO), iStar (STAR), Victory Capital (VCTR), LightPath (LPTH), CIM Commercial Trust (CMCT), Diversified Healthcare Trust (DHC), Arrowhead (ARWR), Customers Bancorp (CUBI), Smith Micro (SMSI), Allogene Therapeutics (ALLO), Stronghold Digital Mining (SDIG), Alta Equipment Group (ALTG), Universal Technical (UTI), Runway Growth Finance (RWAY), Aspen Aerogels (ASPN), Joint Corp. (JYNT), Curis (CRIS), LifeMD (LFMD) and RumbleON (RMBL).

ShowHide Related Items >><<
VCTR Victory Capital
$36.62 /

+0.16 (+0.44%)

UTI Universal Technical
$7.86 /

+ (+0.00%)

STAR iStar
$25.84 /

-0.025 (-0.10%)

SMSI Smith Micro
$4.91 /

-0.01 (-0.20%)

SIMO Silicon Motion
$95.02 /

+1.06 (+1.13%)

SDIG Stronghold Digital Mining
$12.83 /

+0.43 (+3.47%)

RWAY Runway Growth Finance
$12.85 /

+0.01 (+0.08%)

RMBL RumbleON
$41.81 /

-0.69 (-1.62%)

LPTH LightPath
$2.43 /

-0.02 (-0.82%)

LFMD LifeMD
$3.87 /

-0.2 (-4.91%)

JYNT Joint Corp.
$65.63 /

+1.12 (+1.74%)

GSAT Globalstar
$1.16 /

+ (+0.00%)

FRG Franchise Group
$52.16 /

-0.325 (-0.62%)

EVRI Everi Holdings
$21.36 /

+0.22 (+1.04%)

DHX DHI Group
$6.25 /

+0.16 (+2.63%)

DHC Diversified Healthcare Trust
$3.10 /

+0.13 (+4.38%)

DBRG DigitalBridge
$8.34 /

+ (+0.00%)

CUBI Customers Bancorp
$65.40 /

+0.9 (+1.40%)

CRIS Curis
$4.76 /

-0.01 (-0.21%)

ASPN Aspen Aerogels
$49.70 /

+0.73 (+1.49%)

ARWR Arrowhead
$66.34 /

-1.05 (-1.56%)

ALTG Alta Equipment Group
$14.63 /

+0.38 (+2.67%)

ALLO Allogene Therapeutics
$14.94 /

-0.43 (-2.80%)

FRG Franchise Group
$52.16 /

-0.325 (-0.62%)

12/08/21 Barrington
Franchise Group price target raised to $65 from $58 at Barrington
12/08/21 B. Riley
B. Riley remains buyer of Franchise Group after outlook tops estimates
11/23/21 B. Riley
Franchise Group price target raised to $65 from $58 at B. Riley
11/23/21 Barrington
Franchise Group price target raised to $58 from $48 at Barrington
EVRI Everi Holdings
$21.36 /

+0.22 (+1.04%)

11/29/21 B. Riley
B. Riley says focus on domestic gaming suppliers with Macau 'broken'
08/05/21 B. Riley
Everi Holdings price target raised to $39 from $38 at B. Riley
07/09/21 BTIG
Everi Holdings price target raised to $30 from $25 at BTIG
06/22/21 Craig-Hallum
Everi Holdings price target raised to $31 from $27 at Craig-Hallum
TGH Textainer
$35.66 /

+0.1 (+0.28%)

11/05/21 B. Riley
Textainer price target raised to $50 from $42 at B. Riley
06/09/21 B. Riley
Textainer transferred with Buy rating at B. Riley
03/26/21 B. Riley
Textainer price target raised to $42 from $36 at B. Riley Securities
02/18/21 B. Riley
Textainer price target raised to $36 from $31 at B. Riley Securities
GSAT Globalstar
$1.16 /

+ (+0.00%)

12/09/21 B. Riley
B. Riley says 'excellent time' to buy Globalstar on iPhone inclusion evidence
08/30/21 William Blair
Apple may use Iridium connectivity 'down the road,' says William Blair
06/21/21 B. Riley
Globalstar initiated with a Buy at B. Riley
01/22/21 Morgan Stanley
Globalstar downgraded to Underweight after 266% rally at Morgan Stanley
DHX DHI Group
$6.25 /

+0.16 (+2.63%)

12/28/21 Lake Street
Lake Street names 18 small cap best ideas for 2022
12/20/21 Lake Street
DHI Group management meetings increase confidence at Lake Street
11/30/21 Lake Street
DHI Group initiated with a Buy at Lake Street
09/09/21 B. Riley
DHI Group price target raised to $6 from $5.75 at B. Riley
DBRG DigitalBridge
$8.34 /

+ (+0.00%)

12/16/21 RBC Capital
DigitalBridge initiated with an Outperform at RBC Capital
10/07/21 Raymond James
Raymond James upgrades DigitalBridge to Strong Buy after recent weakness
10/07/21 Raymond James
DigitalBridge upgraded to Strong Buy from Outperform at Raymond James
08/09/21 Raymond James
Raymond James starts DigitalBridge at Outperform on shift to digital business
SIMO Silicon Motion
$95.02 /

+1.06 (+1.13%)

12/20/21 Needham
SGH named Top Pick for 2022 at Needham
12/08/21 B. Riley
B. Riley says Silicon Motion buyback better than it appears, ups target
10/29/21 Susquehanna
Silicon Motion upgraded to Positive at Susquehanna
10/29/21 Susquehanna
Silicon Motion upgraded to Positive from Neutral at Susquehanna
STAR iStar
$25.84 /

-0.025 (-0.10%)

09/10/21
Fly Intel: Top five analyst initiations
09/10/21 Berenberg
iStar initiated with a Buy at Berenberg
06/23/21 B. Riley
Safehold initiated with a Buy, $100 target at B. Riley
06/23/21 B. Riley
iStar initiated with a Buy, $35 price target at B. Riley
VCTR Victory Capital
$36.62 /

+0.16 (+0.44%)

12/14/21 B. Riley
Victory Capital selloff brings 'compelling entry point,' says B. Riley
11/11/21 B. Riley
Victory Capital price target raised to $50 from $41 at B. Riley
11/08/21 BMO Capital
Victory Capital price target raised to $54 from $43 at BMO Capital
08/19/21 B. Riley
Victory Capital price target raised to $41 from $38 at B. Riley
LPTH LightPath
$2.43 /

-0.02 (-0.82%)

09/10/21 B. Riley
LightPath price target raised to $3.10 from $2.80 at B. Riley
05/07/21 Alliance Global Partners
LightPath price target lowered to $4 from $5.50 at Alliance Global Partners
05/03/21 B. Riley
LightPath transferred with Buy rating at B. Riley
02/23/21
Fly Intel: Top five analyst initiations
CMCT CIM Commercial Trust
$7.24 /

-0.26 (-3.47%)

10/20/21 B. Riley
CIM Commercial Trust initiated with a Buy at B. Riley
DHC Diversified Healthcare Trust
$3.10 /

+0.13 (+4.38%)

12/30/21 B. Riley
Diversified Healthcare Trust price target raised to $6 from $5 at B. Riley
03/15/21 Morgan Stanley
Morgan Stanley upgrades Physicians Realty to Overweight after underperformance
03/01/21 B. Riley
Diversified Healthcare Trust price target raised to $6 from $5 at B. Riley
ARWR Arrowhead
$66.34 /

-1.05 (-1.56%)

11/16/21 Piper Sandler
Arrowhead selloff on hepatitis B data should be bought, says Piper Sandler
11/15/21 Piper Sandler
Piper Sandler bullish on Arrowhead following updated ARO-AAT, ARO-HSD data
10/29/21 B. Riley
B. Riley keeps $106 target on Arrowhead after ARO-C3 application
10/26/21 Piper Sandler
Key opinion leaders see Arrowhead's C3 as promising target, says Piper Sandler
CUBI Customers Bancorp
$65.40 /

+0.9 (+1.40%)

12/13/21 B. Riley
Customers Bancorp price target raised to $100 from $80 at B. Riley
11/29/21 Wedbush
Customers Bancorp price target raised to $75 from $61 at Wedbush
11/01/21 Piper Sandler
Customers Bancorp price target raised to $57 from $42 at Piper Sandler
10/29/21 B. Riley
Customers Bancorp price target raised to $80 from $60 at B. Riley
SMSI Smith Micro
$4.91 /

-0.01 (-0.20%)

11/11/21 Lake Street
Smith Micro target raised to $9 at Lake Street after 'major' T-Mobile milestone
08/05/21 Dawson James
Smith Micro initiated with a Buy at Dawson James
04/27/21 Benchmark
Smith Micro initiated with a Buy at Benchmark
04/20/21 B. Riley
Smith Micro price target raised to $9.50 from $8 at B. Riley
ALLO Allogene Therapeutics
$14.94 /

-0.43 (-2.80%)

12/14/21 RBC Capital
Allogene Therapeutics price target lowered to $35 from $45 at RBC Capital
12/13/21 Cowen
Allogene Therapeutics named a best idea for 2022 at Cowen
12/03/21 Canaccord
Allogene Therapeutics clinical hold could be lifted shortly, says Canaccord
10/19/21 Cowen
Allogene Therapeutics assumed with an Outperform at Cowen
SDIG Stronghold Digital Mining
$12.83 /

+0.43 (+3.47%)

11/22/21 Compass Point
Stronghold Digital Mining initiated with a Buy at Compass Point
11/16/21 DA Davidson
Stronghold Digital Mining initiated with a Buy at DA Davidson
11/15/21 B. Riley
Stronghold Digital Mining initiated with Buy, $63 target at B. Riley
11/15/21 Northland
Stronghold Digital Mining initiated with an Outperform at Northland
ALTG Alta Equipment Group
$14.63 /

+0.38 (+2.67%)

11/12/21 B. Riley
Alta Equipment Group price target raised to $21 from $19 at B. Riley
05/14/21 B. Riley
Alta Equipment Group price target raised to $19 from $17 at B. Riley
05/14/21 Raymond James
Alta Equipment Group upgraded to Outperform from Market Perform at Raymond James
03/22/21 DA Davidson
Alta Equipment Group price target raised to $16 from $14 at DA Davidson
UTI Universal Technical
$7.86 /

+ (+0.00%)

11/18/21 Barrington
Universal Technical price target raised to $10 from $9 at Barrington
08/03/21 Lake Street
Universal Technical price target raised to $9 at Lake Street after 'good' Q3
RWAY Runway Growth Finance
$12.85 /

+0.01 (+0.08%)

11/15/21 B. Riley
Runway Growth Finance initiated with Buy, $15 target at B. Riley
11/15/21 Compass Point
Runway Growth Finance initiated with a Buy at Compass Point
11/15/21 UBS
Runway Growth Finance initiated with a Buy at UBS
11/15/21 Wells Fargo
Wells Fargo bullish on Runway Growth Finance, initiates with an Overweight
ASPN Aspen Aerogels
$49.70 /

+0.73 (+1.49%)

01/03/22 B. Riley
B. Riley calls Aspen Aerogels a top pick for 2022, ups price target
12/10/21
Fly Intel: Top five analyst initiations
12/10/21 Benchmark
Aspen Aerogels initiated with a Buy at Benchmark
12/03/21 Cowen
Aspen Aerogels price target raised to $67 from $58 at Cowen
JYNT Joint Corp.
$65.63 /

+1.12 (+1.74%)

11/08/21 Roth Capital
Joint Corp. price target raised to $110 from $105 at Roth Capital
10/08/21 Lake Street
Lake Street sees 'fundamental flaws' in short report targeting Joint Corp.
10/08/21 Roth Capital
Joint selloff on short report a buying opportunity, says Roth Capital
08/09/21 DA Davidson
Joint Corp. price target raised to $128 from $65 at DA Davidson
CRIS Curis
$4.76 /

-0.01 (-0.21%)

10/13/21
Fly Intel: Top five analyst initiations
10/13/21 Raymond James
Curis initiated with an Outperform at Raymond James
05/13/21 B. Riley
Curis price target raised to $22 from $19 at B. Riley
05/13/21 Cantor Fitzgerald
Curis price target raised to $24 from $15 at Cantor Fitzgerald
LFMD LifeMD
$3.87 /

-0.2 (-4.91%)

12/27/21 B. Riley
B. Riley recommends LifeMD, OptimizeRx, Semler, Zynex into 2022
11/11/21 BTIG
LifeMD price target lowered to $15 from $30 at BTIG
10/04/21 B. Riley
LifeMD transferred with Buy rating, $16 target at B. Riley
08/13/21 BTIG
LifeMD price target lowered to $30 from $35 at BTIG
RMBL RumbleON
$41.81 /

-0.69 (-1.62%)

11/16/21 Baird
RumbleON price target raised to $52 from $42 at Baird
10/14/21 DA Davidson
RumbleON initiated with a Buy at DA Davidson
09/24/21 B. Riley
B. Riley sees 'significant' appreciation potential for RumbleON shares
09/14/21 Wedbush
RumbleON initiated with an Outperform at Wedbush
VCTR Victory Capital
$36.62 /

+0.16 (+0.44%)

UTI Universal Technical
$7.86 /

+ (+0.00%)

TGH Textainer
$35.66 /

+0.1 (+0.28%)

STAR iStar
$25.84 /

-0.025 (-0.10%)

SMSI Smith Micro
$4.91 /

-0.01 (-0.20%)

SIMO Silicon Motion
$95.02 /

+1.06 (+1.13%)

RMBL RumbleON
$41.81 /

-0.69 (-1.62%)

LPTH LightPath
$2.43 /

-0.02 (-0.82%)

LFMD LifeMD
$3.87 /

-0.2 (-4.91%)

JYNT Joint Corp.
$65.63 /

+1.12 (+1.74%)

GSAT Globalstar
$1.16 /

+ (+0.00%)

FRG Franchise Group
$52.16 /

-0.325 (-0.62%)

EVRI Everi Holdings
$21.36 /

+0.22 (+1.04%)

DHX DHI Group
$6.25 /

+0.16 (+2.63%)

DHC Diversified Healthcare Trust
$3.10 /

+0.13 (+4.38%)

DBRG DigitalBridge
$8.34 /

+ (+0.00%)

CUBI Customers Bancorp
$65.40 /

+0.9 (+1.40%)

CRIS Curis
$4.76 /

-0.01 (-0.21%)

ASPN Aspen Aerogels
$49.70 /

+0.73 (+1.49%)

ARWR Arrowhead
$66.34 /

-1.05 (-1.56%)

ALTG Alta Equipment Group
$14.63 /

+0.38 (+2.67%)

ALLO Allogene Therapeutics
$14.94 /

-0.43 (-2.80%)

  • 18
    Nov
  • 20
    Oct
  • 21
    Oct
  • 29
    Sep
  • 26
    Aug
  • 09
    Apr
  • 11
    Mar
JYNT Joint Corp.
$65.63 /

+1.12 (+1.74%)

GSAT Globalstar
$1.16 /

+ (+0.00%)

DBRG DigitalBridge
$8.34 /

+ (+0.00%)

ARWR Arrowhead
$66.34 /

-1.05 (-1.56%)

UTI Universal Technical
$7.86 /

+ (+0.00%)

SMSI Smith Micro
$4.91 /

-0.01 (-0.20%)

SDIG Stronghold Digital Mining
$12.83 /

+0.43 (+3.47%)

LFMD LifeMD
$3.87 /

-0.2 (-4.91%)

JYNT Joint Corp.
$65.63 /

+1.12 (+1.74%)

GSAT Globalstar
$1.16 /

+ (+0.00%)

DHC Diversified Healthcare Trust
$3.10 /

+0.13 (+4.38%)

DBRG DigitalBridge
$8.34 /

+ (+0.00%)

CMCT CIM Commercial Trust
$7.24 /

-0.26 (-3.47%)

ARWR Arrowhead
$66.34 /

-1.05 (-1.56%)

ALLO Allogene Therapeutics
$14.94 /

-0.43 (-2.80%)

SDIG Stronghold Digital Mining
$12.83 /

+0.43 (+3.47%)

RMBL RumbleON
$41.81 /

-0.69 (-1.62%)

GSAT Globalstar
$1.16 /

+ (+0.00%)

CMCT CIM Commercial Trust
$7.24 /

-0.26 (-3.47%)

ARWR Arrowhead
$66.34 /

-1.05 (-1.56%)

ALLO Allogene Therapeutics
$14.94 /

-0.43 (-2.80%)

Over a month ago
Hot Stocks
Vor Biopharma granted orphan status for leukemia treatment » 09:58
12/17/21
12/17
09:58
12/17/21
09:58
VOR

Vor Biopharma

$12.19 /

+0.09 (+0.74%)

The FDA granted Vor…

The FDA granted Vor Biopharma orphan status for its treatment of acute myeloid leukemia. Reference Link

ShowHide Related Items >><<
VOR Vor Biopharma
$12.19 /

+0.09 (+0.74%)

VOR Vor Biopharma
$12.19 /

+0.09 (+0.74%)

12/17/21 H.C. Wainwright
Vor Biopharma initiated with a Buy at H.C. Wainwright
12/03/21 Baird
Baird start Vor Biopharma with an Outperform ahead of AML data
12/02/21 Baird
Vor Biopharma initiated with an Outperform at Baird
12/01/21 Oppenheimer
Vor Biopharma initiated with an Outperform at Oppenheimer
VOR Vor Biopharma
$12.19 /

+0.09 (+0.74%)

  • 05
    Feb
Initiation
Vor Biopharma initiated with a Buy at H.C. Wainwright » 06:09
12/17/21
12/17
06:09
12/17/21
06:09
VOR

Vor Biopharma

$12.19 /

-0.31 (-2.48%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Swayampakula Ramakanth initiated coverage of Vor Biopharma with a Buy rating and $26 price target. The company is improving hematologic malignancies' treatment through cell and genome engineering, Ramakanth tells investors in a research note. He believes VOR33 will unlock the therapeutic potential of targeting CD33.

ShowHide Related Items >><<
VOR Vor Biopharma
$12.19 /

-0.31 (-2.48%)

VOR Vor Biopharma
$12.19 /

-0.31 (-2.48%)

12/03/21 Baird
Baird start Vor Biopharma with an Outperform ahead of AML data
12/02/21 Baird
Vor Biopharma initiated with an Outperform at Baird
12/01/21 Oppenheimer
Vor Biopharma initiated with an Outperform at Oppenheimer
10/19/21 JMP Securities
Vor Biopharma initiated with an Outperform at JMP Securities
VOR Vor Biopharma
$12.19 /

-0.31 (-2.48%)

  • 05
    Feb
Conference/Events
JMP Securities to hold a virtual summit » 04:55
12/07/21
12/07
04:55
12/07/21
04:55
ALLO

Allogene Therapeutics

$17.19 /

-0.45 (-2.55%)

, BCYC

Bicycle Therapeutics

$50.35 /

-2.24 (-4.26%)

, BCAB

BioAtla

$22.46 /

+0.105 (+0.47%)

, BCRX

BioCryst

$11.18 /

-0.275 (-2.40%)

, BPMC

Blueprint Medicines

$95.36 /

+1.105 (+1.17%)

, CLLS

Cellectis

$8.08 /

-0.18 (-2.18%)

, CGEN

Compugen

$4.20 /

+0.03 (+0.72%)

, CTIC

CTI BioPharma

$1.68 /

+0.075 (+4.69%)

, CUE

Cue Biopharma

$10.94 /

-0.45 (-3.95%)

, CVAC

CureVac

$40.76 /

-2.91 (-6.66%)

, DCPH

Deciphera

$8.03 /

+0.03 (+0.38%)

, EFTR

eFfector Therapeutics

$7.44 /

+1.7 (+29.62%)

, GMDA

Gamida Cell

$2.34 /

-0.015 (-0.64%)

, HOOK

Hookipa Pharma

$2.94 /

+ (+0.00%)

, INBX

Inhibrx

$36.50 /

-0.49 (-1.32%)

, IOVA

Iovance Biotherapeutics

$16.93 /

+0.37 (+2.23%)

, KURA

Kura Oncology

$12.41 /

-0.05 (-0.40%)

, MGN

Mines Management

$1.13 /

+ (+0.00%)

, MOR

MorphoSys

$9.07 /

-0.39 (-4.12%)

, NXTC

NextCure

$5.84 /

+0.1 (+1.74%)

, PTGX

Protagonist Therapeutics

$32.77 /

+0.43 (+1.33%)

, PRTA

Prothena

$44.06 /

-2.565 (-5.50%)

, SPPI

Spectrum

$1.37 /

-0.005 (-0.36%)

, SYRS

Syros Pharmaceuticals

$3.96 /

+0.39 (+10.92%)

, VOR

Vor Biopharma

$13.15 /

+0.5 (+3.95%)

Hematology & Oncology…

Hematology & Oncology Virtual Summit to be held on December 6-7.Webcast Link

ShowHide Related Items >><<
VOR Vor Biopharma
$13.15 /

+0.5 (+3.95%)

SYRS Syros Pharmaceuticals
$3.96 /

+0.39 (+10.92%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

PRTA Prothena
$44.06 /

-2.565 (-5.50%)

NXTC NextCure
$5.84 /

+0.1 (+1.74%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

HOOK Hookipa Pharma
$2.94 /

+ (+0.00%)

GMDA Gamida Cell
$2.34 /

-0.015 (-0.64%)

EFTR eFfector Therapeutics
$7.44 /

+1.7 (+29.62%)

DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CUE Cue Biopharma
$10.94 /

-0.45 (-3.95%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

CLLS Cellectis
$8.08 /

-0.18 (-2.18%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

BPMC Blueprint Medicines
$95.36 /

+1.105 (+1.17%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

12/03/21 Canaccord
Allogene Therapeutics clinical hold could be lifted shortly, says Canaccord
10/19/21 Cowen
Allogene Therapeutics assumed with an Outperform at Cowen
10/12/21 JMP Securities
Allogene Therapeutics price target lowered to $27 from $53 at JMP Securities
10/08/21
Fly Intel: Top five analyst downgrades
BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

10/14/21 JMP Securities
Bicycle Therapeutics price target raised to $85 from $53 at JMP Securities
10/11/21 Canaccord
Bicycle Therapeutics price target raised to $60 from $40 at Canaccord
10/08/21 Oppenheimer
Bicycle Therapeutics price target raised to $65 from $47 at Oppenheimer
10/08/21 B. Riley
Bicycle Therapeutics price target raised to $72 from $56 at B. Riley
BCAB BioAtla
$22.46 /

+0.105 (+0.47%)

10/14/21 BTIG
BioAtla assumed with a Buy at BTIG
06/28/21 Roth Capital
BioAtla initiated with a Buy at Roth Capital
05/04/21 Credit Suisse
BioAtla assumed with an Outperform at Credit Suisse
05/04/21 JPMorgan
BioAtla price target raised to $64 from $45 at JPMorgan
BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

11/22/21 Piper Sandler
BioCryst financing lifts one of two overhangs, says Piper Sandler
11/04/21 Barclays
BioCryst price target lowered to $17 from $21 at Barclays
11/03/21 Piper Sandler
BioCryst earnings pullback a buying opportunity, says Piper Sandler
08/06/21 Jefferies
BioCryst downgraded to Hold from Buy at Jefferies
BPMC Blueprint Medicines
$95.36 /

+1.105 (+1.17%)

12/01/21 Raymond James
Blueprint Medicines added to Analyst Current Favorites list at Raymond James
11/29/21 Stifel
Stifel expects neutral reaction for Blueprint acquisition of Lengo Therapeutics
11/29/21 Piper Sandler
Blueprint acquisition may surprise investors looking for buyout, says Piper
11/19/21 Morgan Stanley
Blueprint Medicines assumed with an Equal Weight at Morgan Stanley
CLLS Cellectis
$8.08 /

-0.18 (-2.18%)

11/30/21 JMP Securities
Cellectis initiated with an Outperform at JMP Securities
11/08/21 William Blair
Cellectis downgraded to Market Perform at William Blair on slow execution
11/08/21 William Blair
Cellectis downgraded to Market Perform from Outperform at William Blair
10/08/21 Baird
Baird cuts Cellectis to Neutral after partner Allogene's clinical hold
CGEN Compugen
$4.20 /

+0.03 (+0.72%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

12/01/21 Lake Street
CTI BioPharma delay creates buying opportunity, says Lake Street
10/04/21 Lake Street
CTI BioPharma should be bought on weakness after PRE-VENT miss, says Lake Street
08/09/21 BTIG
CTI BioPharma initiated with a Buy at BTIG
06/01/21 Lake Street
CTI BioPharma price target raised to $15 from $13 at Lake Street
CUE Cue Biopharma
$10.94 /

-0.45 (-3.95%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

10/22/21
Fly Intel: Top five analyst initiations
10/22/21 Deutsche Bank
CureVac initiated with a Hold at Deutsche Bank
07/01/21 Berenberg
CureVac COVID vaccine data may be enough for EU approval, says Berenberg
06/30/21
CureVac announces COVID vaccine candidate demonstrates 48% efficacy
DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

12/01/21 H.C. Wainwright
Deciphera price target lowered to $15 from $25 at H.C. Wainwright
11/30/21 Piper Sandler
Deciphera price target lowered to $11 from $14 at Piper Sandler
11/08/21 Barclays
Deciphera downgraded to Equal Weight at Barclays after GIST trial miss
11/08/21 Canaccord
Deciphera downgraded to Hold at Canaccord
EFTR eFfector Therapeutics
$7.44 /

+1.7 (+29.62%)

11/08/21 Stifel
eFfector Therapeutics upgraded to Buy at Stifel on NSCLC optimism
11/08/21 Stifel
eFfector Therapeutics upgraded to Buy from Hold at Stifel
10/12/21 Credit Suisse
eFfector Therapeutics initiated with an Outperform at Credit Suisse
10/04/21 Mizuho
eFfector Therapeutics initiated with a Buy at Mizuho
GMDA Gamida Cell
$2.34 /

-0.015 (-0.64%)

11/16/21 H.C. Wainwright
Gamida Cell price target lowered to $22 from $27 at H.C. Wainwright
11/16/21 Oppenheimer
Gamida Cell price target lowered to $15 from $17 at Oppenheimer
11/15/21 Piper Sandler
Gamida Cell price target lowered to $13 from $23 at Piper Sandler
11/01/21 Alliance Global Partners
Gamida Cell initiated with a Buy at Alliance Global Partners
HOOK Hookipa Pharma
$2.94 /

+ (+0.00%)

11/12/21 Morgan Stanley
Morgan Stanley downgrades Hookipa to Equal Weight after oncology data update
11/12/21 Morgan Stanley
Hookipa Pharma downgraded to Equal Weight from Overweight at Morgan Stanley
11/11/21 H.C. Wainwright
Hookipa Pharma price target lowered to $15 from $21 at H.C. Wainwright
11/10/21 JMP Securities
Hookipa Pharma price target lowered to $11 from $25 at JMP Securities
INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

11/10/21 Credit Suisse
Inhibrx price target raised to $53 from $44 at Credit Suisse
11/02/21 JMP Securities
Inhibrx price target raised to $53 from $46 at JMP Securities
09/21/21 JMP Securities
Inhibrx initiated with an Outperform at JMP Securities
04/26/21 Credit Suisse
Inhibrx assumed with an Outperform at Credit Suisse
IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

12/06/21 Cowen
Iovance Biotherapeutics assumed with an Outperform at Cowen
11/15/21 Oppenheimer
Iovance price target lowered to $31 from $38 at Oppenheimer
11/05/21 H.C. Wainwright
Iovance Biotherapeutics price target lowered to $43 from $46 at H.C. Wainwright
11/05/21 Piper Sandler
Iovance Biotherapeutics price target raised to $20 from $18 at Piper Sandler
KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

11/26/21 Credit Suisse
Kura Oncology price target lowered to $21 from $40 at Credit Suisse
11/24/21 H.C. Wainwright
Kura Oncology price target lowered to $32 from $43 at H.C. Wainwright
05/04/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
04/26/21 Credit Suisse
Kura Oncology assumed with an Outperform at Credit Suisse
MGN Mines Management
$1.13 /

+ (+0.00%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

11/12/21 Morgan Stanley
MorphoSys price target raised to EUR 76 from EUR 75 at Morgan Stanley
09/27/21 Citi
MorphoSys downgraded to Neutral from Buy at Citi
09/13/21 Goldman Sachs
MorphoSys reinstated with a Neutral at Goldman Sachs
09/02/21 Barclays
MorphoSys price target lowered to EUR 47 from EUR 90 at Barclays
NXTC NextCure
$5.84 /

+0.1 (+1.74%)

11/05/21 Piper Sandler
NextCure's Phase II NC318 study continuing weekly dosing, says Piper Sandler
08/08/21 Piper Sandler
NextCure price target lowered to $21 from $26 at Piper Sandler
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
03/05/21 Truist
NextCure upgraded to Buy from Hold at Truist
PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

11/15/21 JMP Securities
Protagonist Therapeutics price target raised to $70 from $60 at JMP Securities
11/04/21 Piper Sandler
Piper 'pleasantly surprised' by Protagonist Therapeutics' ASH abstracts
10/13/21 JMP Securities
Protagonist Therapeutics price target raised to $60 from $47 at JMP Securities
10/12/21 JPMorgan
JPMorgan upgrades Protagonist after 'rapid' clinical hold removal
PRTA Prothena
$44.06 /

-2.565 (-5.50%)

11/19/21 JMP Securities
Prothena initiated with an Outperform at JMP Securities
09/30/21 RBC Capital
Prothena price target raised to $82 from $59 at RBC Capital
09/27/21 Oppenheimer
Prothena price target raised to $100 from $90 at Oppenheimer
09/20/21 Fox Advisors
Prothena initiated with an Overweight at Fox Advisors
SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

08/18/21 B. Riley
Spectrum price target lowered to $6 from $8 at B. Riley
06/01/21 H.C. Wainwright
H.C. Wainwright remains bullish on Spectrum as FDA inspects Rolontis facility
SYRS Syros Pharmaceuticals
$3.96 /

+0.39 (+10.92%)

09/27/21 Roth Capital
Veteran Chee coming aboard a positive for Syros, says Roth Capital
09/23/21 Roth Capital
Syros Pharmaceuticals price target raised to $23 from $20 at Roth Capital
05/06/21 Piper Sandler
Syros Pharmaceuticals selloff a buying opportunity, says Piper Sandler
03/05/21 Alliance Global Partners
Syros price target lowered to $14 from $18 at Alliance Global Partners
VOR Vor Biopharma
$13.15 /

+0.5 (+3.95%)

12/03/21 Baird
Baird start Vor Biopharma with an Outperform ahead of AML data
12/02/21 Baird
Vor Biopharma initiated with an Outperform at Baird
12/01/21 Oppenheimer
Vor Biopharma initiated with an Outperform at Oppenheimer
10/19/21 JMP Securities
Vor Biopharma initiated with an Outperform at JMP Securities
VOR Vor Biopharma
$13.15 /

+0.5 (+3.95%)

SYRS Syros Pharmaceuticals
$3.96 /

+0.39 (+10.92%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

PRTA Prothena
$44.06 /

-2.565 (-5.50%)

NXTC NextCure
$5.84 /

+0.1 (+1.74%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

HOOK Hookipa Pharma
$2.94 /

+ (+0.00%)

GMDA Gamida Cell
$2.34 /

-0.015 (-0.64%)

EFTR eFfector Therapeutics
$7.44 /

+1.7 (+29.62%)

DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CUE Cue Biopharma
$10.94 /

-0.45 (-3.95%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

CLLS Cellectis
$8.08 /

-0.18 (-2.18%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

BPMC Blueprint Medicines
$95.36 /

+1.105 (+1.17%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

BCAB BioAtla
$22.46 /

+0.105 (+0.47%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

  • 13
    Oct
  • 11
    Aug
  • 16
    Jun
  • 01
    Apr
  • 24
    Mar
  • 05
    Feb
  • 28
    Jan
  • 20
    Jan
  • 16
    Dec
  • 16
    Dec
  • 11
    Dec
  • 09
    Dec
  • 09
    Dec
SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

PRTA Prothena
$44.06 /

-2.565 (-5.50%)

MOR MorphoSys
$9.07 /

-0.39 (-4.12%)

KURA Kura Oncology
$12.41 /

-0.05 (-0.40%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

DCPH Deciphera
$8.03 /

+0.03 (+0.38%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

CTIC CTI BioPharma
$1.68 /

+0.075 (+4.69%)

CGEN Compugen
$4.20 /

+0.03 (+0.72%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

SPPI Spectrum
$1.37 /

-0.005 (-0.36%)

PTGX Protagonist Therapeutics
$32.77 /

+0.43 (+1.33%)

IOVA Iovance Biotherapeutics
$16.93 /

+0.37 (+2.23%)

INBX Inhibrx
$36.50 /

-0.49 (-1.32%)

CVAC CureVac
$40.76 /

-2.91 (-6.66%)

BCYC Bicycle Therapeutics
$50.35 /

-2.24 (-4.26%)

BCRX BioCryst
$11.18 /

-0.275 (-2.40%)

BCAB BioAtla
$22.46 /

+0.105 (+0.47%)

ALLO Allogene Therapeutics
$17.19 /

-0.45 (-2.55%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.